4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-19-012154
President and General Counsel sold 7,500 shares at $24.99 ($187,425)
- President and General Counsel acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2019-03-01 | Option exercise | +7,500 | $20.26 | $151,950 | 175,818 | D |
| Shandell Jason B. President and General Counsel | 2019-03-01 | Sale | −7,500 | $24.99 | $187,425 | 168,318 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2019-03-01 | Option exercise · Employee Stock Option (right to buy) | −7,500 | 0 | D | ||
| Open-market sales · 7,500 sh · avg $24.99 · $187,425 | |||||||
Loading xslF345X03/a4.xml…